PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Department of Endocrinology, Queen Elizabeth Hospital Birmingham, University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK.\', \'Centre for Endocrinology, Diabetes and Metabolism, Birmingham Health Partners, Birmingham, UK.\', \'Institute of Metabolism and Systems Research, College of Medical and Dental Sciences, University of Birmingham, Birmingham, UK.\', \'Centre for Bone Quality, Leiden University Medical Centre, Leiden, The Netherlands.\', \'Section of Specialized Endocrinology, Oslo University Hospital, Oslo, Norway.\', \'Faculty of Medicine, University of Oslo, Oslo, Norway.\', \'Departments of Orthopaedics and Medicine, UConn Health, Farmington, Connecticut, USA.\', \'Department of Endocrinology and Internal Medicine, Aarhus University Hospital, Aarhus, Denmark.\']
?:citedBy
  • -1
?:creator
?:doi
  • 10.1530/EJE-20-0385EJE-20-0385
?:doi
?:hasPublicationType
?:journal
  • European journal of endocrinology
is ?:pmid of
?:pmid
?:pmid
  • 32396134
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 1.892
?:rankingScore_hIndex
  • 126
is ?:relation_isRelatedTo_publication of
?:title
  • ENDOCRINOLOGY IN THE TIME OF COVID-19: Management of calcium metabolic disorders and osteoporosis.
?:type
?:year
  • 2020

Metadata

Anon_0  
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/net/provenance/ns#DataItem>
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2004/03/trix/rdfg-1/Graph>
<http://xmlns.com/foaf/0.1/primaryTopic> <https://research.tib.eu/covid-19/entity/32396134>
<http://xmlns.com/foaf/0.1/topic> Anon_0
<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes> <https://research.tib.eu/covid-19/data/entity/32396134>
<http://purl.org/net/provenance/ns#createdBy>
Anon_1   (more)
expand all